
Heart World Conference 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Heart World Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Heart World Conference 2026
Heart World Conference 2026 is positioned as a global, cardiology-focused medical and scientific gathering where clinical decision-makers, healthcare leaders, researchers, and industry partners converge to advance cardiovascular care. Based on the typical structure of large international heart and cardiovascular conferences, the audience usually includes cardiology specialists, hospital administrators, academic researchers, and organizations that support diagnostics, treatment, and patient outcomes across the heart disease care pathway.
1) Who attends (BUYERS / ATTENDEES)
This event’s attendance mix typically spans two layers: (1) clinical and academic attendees who influence medical practice and research direction, and (2) organizational and industry attendees who sponsor, exhibit, and evaluate solutions. For a buyer-oriented perspective, the strongest buyer-fit groups are usually found among the decision-makers that operate within healthcare organizations, academic institutions, and cardiovascular programs.
- Clinicians and specialists: cardiologists (interventional, electrophysiology, heart failure), cardiac imaging specialists, and related sub-specialists who attend scientific sessions and symposia.
- Healthcare leadership: hospital executives, department heads, medical directors, and cardiovascular program leaders who oversee service expansion and partnerships.
- Academia and research: university researchers, clinical trial coordinators, translational medicine teams, and research administrators focused on studies and publications.
- Industry decision-makers: representatives from medical device, diagnostic, digital health, and pharmaceutical companies who lead strategy for cardiology products and clinical adoption pathways.
- Allied healthcare stakeholders: nurses, cardiac rehabilitation leaders, and specialists involved in patient management and long-term care models.
- Policy and guideline contributors: professional society members and organizations that support education, standards, and guideline dissemination.
2) Where the show is happening + attendee geographic origin
As we finalize the attendee geography analysis, we would map the conference’s location and historical attendance patterns (host-country medical institutions, regional referrals, and international speaker participation). For global cardiovascular conferences, attendee origin typically clusters into:
- Host country: local hospitals, national societies, and regional cardiovascular centers.
- Regional neighbors: countries with travel convenience, shared clinical networks, and similar regulatory environments.
- International professionals: clinicians and research groups who travel for flagship sessions, major keynote speakers, and high-impact abstracts.
If we receive the conference’s venue city/country and organizer-provided attendance footprint, we can convert this into a concrete “where attendees come from” breakdown tailored for research targeting.
3) Audience reach (Local / National / Global)
Heart World Conference 2026 is expected to have a global reach if it follows the typical pattern of international heart and cardiology congresses: global industry participation, multi-region clinical attendance, and international medical research representation. The practical outcome for buyer research is that the event usually supports both:
- International brand discovery: sponsors and exhibitors from multiple geographies
- Cross-border clinical collaboration: shared protocols, research networks, and multi-country evidence exchange
Once the event’s official scope is confirmed (international congress vs. regional summit), we can label the reach accurately as local, national, or global and estimate the balance between them.
4) Sample buyer company names (BUYERS ONLY) + websites
Below are illustrative buyer-fit examples commonly associated with cardiology conferences (medical devices, diagnostics, cardiovascular services, and digital health). We will refine this list to match the exact conference exhibitors once we have the event’s exhibitor list and sponsor roster.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Medtronic | https://www.medtronic.com | VP, Cardiovascular/Structural Heart Marketing; Product Marketing Director (Cardiology) | Strong relevance for implantable cardiology technologies and cardiovascular product adoption pathways. |
| 2 | Abbott | https://www.abbott.com | Director, Cardiac Diagnostics; Global Marketing Manager (Cardiovascular) | Fits cardiovascular diagnostics, monitoring, and clinical workflow integration needs. |
| 3 | Boston Scientific | https://www.bostonscientific.com | Strategic Marketing Manager (Cardiology); Sales Director, Interventional Cardiology | Excellent fit for interventional cardiology devices and hospital adoption decision-makers. |
| 4 | Siemens Healthineers | https://www.siemens-healthineers.com | Clinical Segment Leader (Cardiology); Imaging Solutions Manager | Imaging and diagnostic infrastructure are central to modern heart care and conference programs. |
| 5 | Philips | https://www.philips.com | Head of Cardiology Solutions; Director, Connected Care (Cardio) | Supports imaging, monitoring, and care coordination—highly aligned with conference themes. |
| 6 | GE HealthCare | https://www.gehealthcare.com | Director, Cardiology Imaging; Product Manager, Ultrasound/CT/MRI (Cardio) | Strong alignment for advanced imaging systems used for cardiovascular diagnosis and treatment planning. |
| 7 | Roche Diagnostics | https://diagnostics.roche.com | Senior Product Manager (Cardiology/Diagnostics); Director, Clinical Strategy | Fit for diagnostic innovation and clinical evidence pathways for cardiovascular markers. |
| 8 | Johnson & Johnson / Janssen | https://www.janssen.com | Medical Affairs Director (Cardiovascular); Clinical Operations Lead | Fits cardiovascular medicines and evidence development that are typically core to heart conferences. |
| 9 | Bayer | https://www.bayer.com | Head of Cardiovascular Product Strategy; Market Access Director (Cardio) | Strong fit for cardiovascular therapeutics and payer/policy-aware strategy conversations. |
| 10 | Novartis | https://www.novartis.com | Director, Cardiovascular Portfolio Marketing; Market Access Manager | Broad relevance to cardiovascular therapies and clinical education agendas. |
| 11 | Pfizer | https://www.pfizer.com | Director, CV Clinical Strategy; Therapeutic Area Lead (Cardiovascular) | Aligned with evidence generation, clinician education, and adoption planning for CV therapies. |
| 12 | Boston Scientific | https://www.bostonscientific.com | Regional Sales Director, Cardiology; Head of Clinical Education (CV) | Conference-driven education and adoption planning typically attract decision-makers who manage clinical training. |
| 13 | Telehealth / Digital Cardiovascular Solutions Co. (category) | — | Director, Digital Health Partnerships (Cardio); VP, Remote Monitoring | Many heart conferences actively spotlight remote monitoring, patient pathways, and adherence programs. |
| 14 | Cardiac Rehab & Care Delivery Networks (category) | — | VP Clinical Operations (Cardiac); Director of Programs (Rehabilitation) | Rehab pathways and long-term outcomes are recurring conference priorities for buyer-fit attendees. |
| 15 | Contract Research Organizations (category) | — | Director, Clinical Trials (Cardiology); Partnerships Manager (Clinical) | Cardiology research and trials drive CRO participation in many medical congress environments. |
Note: we can replace “category” placeholders with specific company accounts once the organizer’s exhibitor and sponsor lists are provided.
5) Job profiles, industries & event type
Event type (expected)
- Medical conference / cardiology congress
- Clinical education & scientific sessions
- Industry exhibit hall focused on cardiovascular solutions
- Research and clinical trials presentations
- Workshops for imaging, intervention, diagnostics, and patient pathways
Job profiles to target
- Medical Affairs Director / Medical Science Liaison (Cardiovascular)
- Director, Clinical Strategy (CV); Clinical Operations Lead
- Product Manager / Product Marketing Director (Cardiology)
- Regional Sales Director (Cardiology / Interventional)
- Head of Cardiology Solutions; Segment Leader (Diagnostics/Imaging)
- Market Access Director; Pricing & Reimbursement Manager
- Hospital Cardiovascular Program Director; Cardiology Department Head
- Research Administrator / Clinical Trials Coordinator
- Connected Care or Remote Monitoring Partnerships Lead
Industries commonly aligned to this event
- Medical Devices
- Pharmaceuticals
- Hospital & Health Care
- Information Technology & Services (digital health, monitoring platforms)
- Research
- Medical Practice
- Biotechnology
- Telecommunications (when remote patient monitoring is part of the program)
6) Estimated attendance (expected total footfall)
Heart World Conference 2026’s estimated footfall typically depends on whether it is an international multi-day congress with parallel tracks and a large exhibition. In most cardiology conferences with sponsor-driven exhibition halls, total attendance often includes:
- Clinical attendees from hospitals and academic centers
- Industry participants (exhibitors, sponsors, clinical education teams)
- Researchers and study coordinators
- Allied health professionals and healthcare administrators
We will provide a numeric attendance estimate once we confirm the official attendance range from event announcements or the organizer’s media kit. If you share the venue capacity and session format (single-track vs. parallel tracks), we can also estimate day-by-day footfall more accurately.
7) Key focus areas & buyer engagement
Cardiovascular conferences typically concentrate on both clinical innovation and implementation—so buyer engagement is often strongest around actionable themes such as:
- Diagnosis and imaging advancements: imaging workflows, cardiac diagnostics, and interpretation tools
- Interventional cardiology: procedures, devices, and best-practice adoption
- Heart failure & chronic care pathways: patient management models and long-term outcomes
- Electrophysiology and rhythm management: innovation in monitoring and interventions
- Clinical evidence and trials: trial design, evidence updates, and real-world evidence
- Guidelines and education: continuing medical education and guideline translation
- Connected care and remote monitoring: digital tools that improve adherence and monitoring
- Market access and adoption: strategies that help solutions reach healthcare systems
The engagement approach that works best for buyer research is to align to “solution adoption” language rather than generic networking: we focus on collecting decision-makers tied to cardiology programs, clinical strategy, and product adoption initiatives.
8) Client-product fit note (please share the client website)
To identify the best-fit buyer accounts for Heart World Conference 2026 based on your client’s actual requirements, we need the client website. Please share the website URL so we can review what they sell (e.g., devices, diagnostics, pharmaceuticals, digital health, training, services) and then map the likely buyer profiles accordingly.
Once the client website is provided, we will:
- Filter buyer titles that match the client’s procurement/adoption stakeholders
- Prioritize companies whose portfolios align with the conference’s cardiology themes
- Recommend the highest-likelihood buyer segments to focus on for your research
- Produce a refined buyer table with priority ranking and role targeting
This ensures the output is not generic; it is tailored to the client’s cardiology market and buying decision logic.
9) Industry suggestions (based on the industry list you provided)
For Heart World Conference 2026, the most relevant industries from your list are typically:
- Hospital & Health Care
- Hospitality (only if the conference organizer includes healthcare travel/services; otherwise optional)
- Medical Devices
- Medical Practice
- Pharmaceuticals
- Biotechnology
- Research
- Health, Wellness & Fitness (for rehab/wellness programs, secondary alignment)
- Internet and Information Technology & Services (for digital health, remote monitoring, connected platforms)
- Telecommunications (when monitoring and connectivity partners are present)
- Professional Training & Coaching (only if the agenda includes clinical education/training programs)
Quick next step
Please share the client website (and ideally a 2–3 line description of what they offer) so we can determine the best-fit buyer profiles and produce a prioritized buyer list aligned to Heart World Conference 2026.
Data sheet
| Event Name | Heart World Conference 2026 |
| Event Date | 12 Nov 2026 – 14 Nov 2026 |
| Event Status | Upcoming |
| Venue | Village Hotel Changi |
| City | Singapore City |
| State / Region | Singapore |
| Country | Singapore |
| Organizer | Not publicly confirmed in the provided event details |
| Official Event Website | Not publicly confirmed in the provided event details |
| Event Type | Conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research, Wellness, Health & Fitness |
| Audience Reach | Regional / International healthcare audience, subject to organizer’s final distribution |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; no verified current-year public attendance figure found in the provided details |
| Main Purpose of Event | Professional exchange on cardiovascular care, clinical innovation, research, treatment pathways, and healthcare partnerships |
Heart World Conference 2026 appears to be a healthcare-focused conference centered on cardiology, cardiovascular treatment, and related clinical or research topics. Based on the event title and format, it is likely designed to bring together clinicians, researchers, hospital leaders, medical technology providers, and healthcare stakeholders seeking updates on diagnosis, intervention, prevention, and patient management.
The event matters because cardiovascular care remains a high-priority area for hospitals, specialist practices, medtech suppliers, and public health stakeholders. For exhibitors and sponsors, this type of conference is typically valuable for lead generation, education, product awareness, scientific engagement, and relationship-building with decision-makers involved in procurement, clinical adoption, and innovation evaluation.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical decision-makers | Hospitals, cardiac centers, specialist clinics | Evaluate therapies, devices, and clinical protocols | High relevance for medtech, diagnostics, and treatment solutions |
| Procurement and sourcing teams | Hospitals, health systems, group purchasing organizations | Control sourcing, vendor approval, and contract awards | Key for supplier qualification and pipeline development |
| Department heads and medical directors | Cardiology departments, critical care units, imaging departments | Influence clinical standardization and technology selection | Useful for solution selling and adoption discussions |
| Hospital administrators / operations leaders | Private hospitals, public hospitals, health groups | Own service-line performance, budgets, and implementation | Relevant for capital equipment, workflow, and service contracts |
| Biomedical / clinical engineering teams | Hospitals, healthcare networks | Assess device integration, maintenance, and compliance | Important for equipment, monitoring, and interoperability vendors |
| Researchers and academic leaders | Medical schools, universities, research institutes | Influence evidence generation, trials, and thought leadership | Useful for research partnerships and innovation adoption |
| Industry consultants and advisors | Healthcare consultants, advisory firms, KOL networks | Shape buying recommendations and vendor shortlists | Helpful for indirect influence and relationship building |
| Association leaders and society officers | Medical associations, professional societies | Set agendas, standards, and event partnerships | Useful for sponsorship, education, and alliance opportunities |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Singapore City | High | Strong concentration of hospitals, medtech firms, and healthcare HQ functions |
| Host state / region | Singapore | High | National healthcare and research ecosystem with centralized decision-making |
| Nearby business hubs | Shenton Way, Marina Bay, Changi, one-north | Medium to High | Relevant for healthcare HQ, innovation, and regional procurement teams |
| National reach | Singapore-wide hospitals and health organizations | High | Likely attendance from public and private healthcare systems |
| International reach | ASEAN, APAC, and selected global attendees | Medium | Singapore is a regional medical and conference hub; cross-border attendance is plausible |
| Trade / care corridors | Malaysia, Indonesia, Thailand, Philippines, Vietnam | Medium | Likely source markets for clinicians, distributors, and healthcare buyers |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Secondary possibility | Singapore is a major international conference destination; however, the current event’s official global reach is not publicly confirmed. |
| Regional | Primary classification | Most likely draw from Southeast Asia and APAC healthcare markets. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| National Heart Centre Singapore | Cardiac care provider | High-fit cardiac treatment and specialist care organization | nhcs.com.sg | Medical Director, Department Head, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| National University Heart Centre, Singapore | Academic cardiac center | Likely to participate in clinical, research, and innovation sessions | nuhcs.com.sg | Clinical Director, Research Lead, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Singapore General Hospital | Public hospital | Large-scale hospital buyer with cardiology and procurement functions | singhealth.com.sg | Procurement Director, Operations Director, Cardiology Head | Strong Market Fit, Attendance Not Confirmed |
| Tan Tock Seng Hospital | Public hospital | Relevant hospital buyer for cardiology equipment and clinical solutions | ttsh.com.sg | Supply Chain Manager, Clinical Head, Biomedical Engineering Lead | Strong Market Fit, Attendance Not Confirmed |
| National Heart Institute | Cardiology institute | Regional cardiac care benchmark with procurement and research relevance | jnj.com? not applicable | Director, Procurement, Clinical Operations | Strong Market Fit, Attendance Not Confirmed |
| Bumrungrad International Hospital | Private hospital | High-value private healthcare buyer for advanced cardiology solutions | bumrungrad.com | Chief Medical Officer, Procurement, Service Line Director | Strong Market Fit, Attendance Not Confirmed |
| Mount Elizabeth Hospitals | Private hospital network | Premium hospital buyer for specialized cardiovascular services | mountelizabeth.com.sg | Hospital Director, Procurement Manager, Cardiology Lead | Strong Market Fit, Attendance Not Confirmed |
| IHH Healthcare | Healthcare group / operator | Multi-hospital operator with regional purchasing leverage | ihhhealthcare.com | Group Procurement, Operations, Clinical Innovation | Strong Market Fit, Attendance Not Confirmed |
| Philips | Medical technology supplier / buyer-side influencer | Relevant for ecosystem partnerships and clinical technology evaluation | philips.com | Business Development, Product Manager, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical device company | Cardiovascular portfolio aligns with clinical and procurement audience | medtronic.com | Country Manager, Product Director, Clinical Affairs | Strong Market Fit, Attendance Not Confirmed |
| Abbott | Medical devices / diagnostics | Relevant for cardiovascular devices, diagnostics, and care pathways | abbott.com | Sales Director, Product Manager, Clinical Specialist | Strong Market Fit, Attendance Not Confirmed |
| Boston Scientific | Medical device company | Core cardiovascular solutions supplier and KOL engagement target | bostonscientific.com | Regional Manager, Marketing Manager, Medical Affairs | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Clinical Leadership | C-Level | Influences clinical strategy, adoption, and vendor prioritization |
| 2 | Cardiology Department Head | Clinical Operations | Director / Head | Owns service-line needs and product evaluation |
| 3 | Procurement Director | Procurement | Director | Controls buying decisions and vendor onboarding |
| 4 | Strategic Sourcing Manager | Supply Chain / Procurement | Manager | Evaluates suppliers, tenders, and cost-effectiveness |
| 5 | Hospital Operations Director | Operations | Director | Responsible for workflow, service delivery, and implementation |
| 6 | Biomedical Engineering Manager | Engineering / Facilities | Manager | Assesses device compatibility, maintenance, and safety |
| 7 | Clinical Affairs Manager | Clinical / Regulatory | Manager | Supports evidence review and adoption of therapies |
| 8 | Research Director | Research | Director | Drives clinical trials, publications, and innovation partnerships |
| 9 | Partnerships Director | Business Development | Director | Useful for alliance, sponsorship, and channel discussions |
| 10 | Product Manager | Product / Commercial | Manager | Supports vendor evaluation and market feedback loops |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core sector for cardiology buyers and service-line leaders | Hospitals, clinics, health systems |
| 2 | Medical Devices | High relevance for treatment and monitoring tools | Device OEMs, buyers, and evaluators |
| 3 | Pharmaceuticals | Relevant for treatment pathways and cardiovascular drugs | Medical affairs, marketing, strategic accounts |
| 4 | Biotechnology | Innovation, diagnostics, and therapeutic research relevance | R&D partnerships and trial collaborations |
| 5 | Research | Academic and applied research participation is likely | Clinical studies and evidence generation |
| 6 | Biotechnology | Biologic and diagnostic innovation overlap | Pipeline scouting and strategic partnerships |
| 7 | Health, Wellness & Fitness | Relevant if event includes prevention and care management | Wellness services and patient engagement solutions |
| 8 | Government Administration | Public healthcare buyers and policy stakeholders may attend | Public hospital procurement and policy outreach |
| 9 | Information Technology & Services | Useful if digital health, data, or workflow tech is part of agenda | Digital health, analytics, interoperability |
| 10 | Medical Practice | Specialist clinicians are likely attendee influencers | Private practices and specialist groups |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unknown | No verified public organizer data provided | Use organizer registration or brochure for final count |
| Exhibitor count | Not publicly confirmed | Unknown | No verified current-year exhibitor directory available in provided details | Could be a conference without a major expo floor |
| Buyer count | Not publicly confirmed | Unknown | No verified buyer list provided | Buyer intent likely concentrated in hospitals and medtech |
| Speaker count | Not publicly confirmed | Unknown | No official agenda supplied | Speaker quality would materially affect lead value |
| Sponsor count | Not publicly confirmed | Unknown | No official sponsor prospectus supplied | Sponsor roster would indicate commercial value and market depth |
| Historical attendance | Not publicly confirmed | Unknown | No verified prior-year official attendance figure available | Attendance figure not publicly confirmed by the organizer. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical innovation | Need evidence-based improvements in patient outcomes | Scientific sessions, KOL engagement, demo discussions | Devices, diagnostics, digital clinical tools |
| Procurement | Need reliable, compliant vendors with strong value proposition | Vendor qualification and sourcing conversations | Equipment, consumables, service contracts |
| Research and trials | Need study collaboration and data generation support | Academic networking and research partnership outreach | Clinical research services, trial support, analytics |
| Digital health | Need interoperability, remote monitoring, and workflow efficiency | Product demos and implementation discussions | Software, data platforms, telehealth solutions |
| Education and training | Need continuing education and clinical upskilling | Workshop sponsorship and CME-aligned messaging | Training content, certification, simulation tools |
| Facility and equipment management | Need safe uptime and lifecycle support | Facilities and biomedical engineering conversations | Maintenance, service, spare parts, installations |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Likely attracts hospitals, clinicians, and medtech stakeholders with real purchasing influence |
| Decision-maker availability | High | Healthcare conferences often include department heads, procurement, and clinical leaders |
| Data collection potential | Medium | Potentially strong if attendee, speaker, or sponsor list is released |
| Apollo targeting potential | High | Strong fit for hospital, medical devices, pharma, biotech, and research targeting |
| Geographic targeting potential | High | Singapore plus regional APAC healthcare organizations are targetable |
| Best outreach approach | High-touch email + LinkedIn + event-based call follow-up | Use clinical relevance, procurement value, and regional credibility messaging |
| Overall lead quality | High | Strong if the event is supported by a real attendee or sponsor ecosystem |
| Best use case | Lead generation, attendee intelligence, medtech targeting, partnership development | Best for targeting healthcare decision-makers and regional distributors |
| Limitations / risks | Moderate | No verified organizer, exhibitor, or attendance list was provided in the available event details |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Medical Practice | Align with likely attendee and buyer ecosystem |
| Departments | Procurement, Operations, Clinical Affairs, Medical Affairs, Research, Business Development | Reach buying and influence functions |
| Seniority | Manager, Director, VP, CXO, Head | Focus on decision-makers and budget owners |
| Job titles | Procurement Director, Supply Chain Manager, Cardiology Head, Clinical Director, Medical Director, Operations Director, Biomedical Engineering Manager | Target roles likely to influence vendor selection |
| Geography | Singapore; Malaysia; Indonesia; Thailand; Philippines; Vietnam; APAC | Match likely attendee origin and regional expansion opportunity |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,000+ | Covers private clinics through large hospital groups and OEMs |
| Keywords | cardiology OR cardiovascular OR heart OR cath lab OR ECG OR hemodynamic OR patient monitoring OR medical device OR hospital procurement | Improve relevance for healthcare-specific buyer discovery |
| Company type | Hospital systems, specialist clinics, private hospital groups, medtech manufacturers, diagnostic firms, research institutions | Prioritize organizations with real purchasing or influence capacity |
| Revenue range | Optional: $10M+ for device/service suppliers; $100M+ for larger strategic accounts | Refines target quality for enterprise outreach |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Village Hotel Changi | Venue website | Venue identity and location context for Singapore event hosting | High |
| Visit Singapore | Destination / government tourism site | Singapore’s position as an international meetings destination | Medium |
| HealthHub Singapore | Government health information source | General healthcare relevance and cardiovascular care context | Medium |
| Provided event details | User-supplied event data | Event name, date, venue, city, and country | Medium |
| No official event website verified | Verification note | Could not confirm organizer, agenda, exhibitor list, or attendance figure from a primary event source | Low |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Heart World Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.